Sector: Health Care.Industry: Biotechnology
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).
Earnings
see more| Q4 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-06-28 | ||||||
| REV | |||||||
| Q3 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.320 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IMVT | Immunovant | 0.61% | 1.6B |
Immunovant Company Questions & Answers
Q
How do I buy Immunovant (IMVT) stock?
A
You can purchase shares of Immunovant (NASDAQ: IMVT) through any online brokerage.
Q
Who are Immunovant's (IMVT) main competitors?
A
Other companies in Immunovant’s space includes: Replimune Group (NASDAQ:REPL), Cerevel Therapeutics Hldg (NASDAQ:CERE) and Arcutis Biotherapeutics (NASDAQ:ARQT).
Q
What is the target price for Immunovant?
A
The latest price target for Immunovant (NASDAQ: IMVT) was reported by Credit Suisse on 2021-02-17. The analyst firm set a price target for 26.00 expecting IMVT to rise to within 12 months (a possible 57.58% upside). 18 analyst firms have reported ratings in the last year.
Q
How much is Immunovant (IMVT) stock ?
A
The stock price for Immunovant (NASDAQ: IMVT) is $16.5 last updated Today at 2:51:00 PM.
Q
When is the next Immunovant (IMVT) dividend?
A
There are no upcoming dividends for Immunovant.
Q
When is Immunovant (NASDAQ:IMVT) reporting earnings?
A
Immunovant’s Q4 earnings are confirmed from now on June 28, 2021.
Q
When is the upcoming split for IMVT?
A
There is no upcoming split for Immunovant.